26.22
0.19%
+0.05
Intellia Therapeutics Inc Azioni (NTLA) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 |
Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
Revenues |
115.99%
-1.917
|
11.99 | 13.59 | 12.61 | 13.57 |
Operating Expenses
|
3.58%
137.97
|
143.10 | 145.93 | 124.56 | 123.66 |
Benefits Costs and Expenses |
8.98%
130.24
|
143.10 | 145.93 | 115.73 | 126.98 |
Costs And Expenses |
3.58%
137.97
|
143.10 | 145.93 | 124.56 | 123.66 |
Operating Income/Loss |
6.70%
-139.89
|
-131.11 | -132.33 | -111.96 | -110.09 |
Income/Loss Before Equity Method Investments |
0.14%
-127.43
|
-127.25 | -128.33 | -100.08 | -110.16 |
Income/Loss From Equity Method Investments |
22.58%
-4.728
|
-3.857 | -4.00 | -3.048 | -3.248 |
Income/Loss From Continuing Operations Before Tax |
0.80%
-132.16
|
-131.11 | -123.68 | -103.13 | -113.41 |
Income/Loss From Continuing Operations After Tax |
8.13%
-132.16
|
-122.22 | -123.68 | -103.13 | -113.41 |
Net Income/Loss
|
8.13%
-132.16
|
-122.22 | -123.68 | -103.13 | -113.41 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
99.36%
0.566
|
88.64 | 88.19 | 87.77 | 1.429 |
Diluted Average Shares |
99.36%
0.566
|
88.64 | 88.19 | 87.77 | 1.429 |
Basic Earnings Per Share |
5.80%
-1.46
|
-1.38 | -1.40 | -1.17 | -1.38 |
Diluted Earnings Per Share |
5.80%
-1.46
|
-1.38 | -1.40 | -1.17 | -1.38 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
Capitalizzazione:
|
Volume (24 ore):